Tejas Patel

ORCID: 0000-0002-8766-5632
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacovigilance and Adverse Drug Reactions
  • Drug-Induced Adverse Reactions
  • COVID-19 Clinical Research Studies
  • Pharmaceutical studies and practices
  • Pharmaceutical Practices and Patient Outcomes
  • Long-Term Effects of COVID-19
  • Global Health Care Issues
  • Global Maternal and Child Health
  • SARS-CoV-2 and COVID-19 Research
  • Healthcare Systems and Reforms
  • Anesthesia and Pain Management
  • Anesthesia and Sedative Agents
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Innovations in Medical Education
  • Antibiotic Use and Resistance
  • Analytical Methods in Pharmaceuticals
  • Innovative Teaching Methods
  • Autoimmune Bullous Skin Diseases
  • Schizophrenia research and treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Antibiotic Resistance in Bacteria
  • Drug-Induced Hepatotoxicity and Protection
  • Sepsis Diagnosis and Treatment
  • Patient Safety and Medication Errors
  • Intensive Care Unit Cognitive Disorders

All India Institute of Medical Sciences
2020-2025

All India Institute of Medical Sciences Raipur
2021-2025

Baba Raghav Das Medical College
2020-2024

All India Institute of Medical Sciences Bhopal
2021-2023

Pramukhswami Medical College
2023

New York University
2023

Universidad del Noreste
2023

Care Institute of Medical Sciences
2021

Sir Sayajirao General Hospital Medical College
2013-2019

Bankstown Lidcombe Hospital
2019

Joseph L. Dieleman Madeline Campbell Abigail Chapin Erika Eldrenkamp Victoria Y. Fan and 95 more Annie Haakenstad Jennifer Kates Yingying Liu Taylor Matyasz Angela E Micah Alex Reynolds Nafis Sadat Matthew Schneider Reed J D Sorensen Tim Evans David Evans Christoph Kurowski Ajay Tandon Kaja Abbas Semaw Ferede Abera Ali Kiadaliri Kedir Y. Ahmed Muktar Beshir Ahmed Khurshid Alam Reza Alizadeh‐Navaei Ala’a Alkerwi Erfan Amini Walid Ammar Stephen M. Amrock Carl Abelardo T. Antonio Tesfay Mehari Atey Leticia Ávila‐Burgos Ashish Awasthi Aleksandra Barać Óscar Bernal Addisu Shunu Beyene Tariku J. Beyene Charles Birungi Habtamu Mellie Bizuayehu Nicholas J K Breitborde Lucero Cahuana-Hurtado Rubén Castro Ferrán Catalá-López Koustuv Dalal Lalit Dandona Rakhi Dandona Pieter de Jager Samath D Dharmaratne Manisha Dubey Carla Sofia e Sá Farinha André Faro Andrea B Feigl Florian Fischer Joseph R A Fitchett Nataliya A Foigt Ababi Zergaw Giref Rahul Gupta Samer Hamidi Hilda L Harb Simon I Hay Delia Hendrie Masako Horino Mikk Jürisson Mihajlo Jakovljević Mehdi Javanbakht Denny John Jost B. Jonas Saeed Karimi Young‐Ho Khang Jagdish Khubchandani Young‐Eun Kim Jonas M Kinge Kristopher J Krohn G Anil Kumar Hassan Magdy Abd El Razek Mohammed Magdy Abd El Razek Azeem Majeed Reza Malekzadeh Felix Masiye Toni Meier Atte Meretoja Ted R. Miller Erkin М Мirrakhimov Shafiu Mohammed Vinay Nangia Stefano Olgiati Abdalla Sidahmed Osman Mayowa Owolabi Tejas Patel Ángel Paternina‐Caicedo David M. Pereira Julian Perelman Suzanne Polinder Anwar Rafay Vafa Rahimi‐Movaghar Rajesh Kumar Usha Ram Chhabi Lal Ranabhat Hirbo Shore Roba Joseph S Salama

<h2>Summary</h2><h3>Background</h3> An adequate amount of prepaid resources for health is important to ensure access services and the pursuit universal coverage. Previous studies on global financing have described relationship between economic development financing. In this study, we further explore trends examine how sources funds used, types purchased, assistance disbursed change with development. We also identify countries that deviate from trends. <h3>Methods</h3> estimated national...

10.1016/s0140-6736(17)30874-7 article EN cc-by The Lancet 2017-04-19
Joseph L. Dieleman Nafis Sadat Angela Y. Chang Nancy Fullman Cristiana Abbafati and 95 more Pawan Acharya Arsène Kouablan Adou Ali Kiadaliri Khurshid Alam Reza Alizadeh‐Navaei Ala’a Alkerwi Walid Ammar Carl Abelardo T. Antonio Olatunde Aremu Solomon Weldegebreal Asgedom Tesfay Mehari Atey Leticia Ávila‐Burgos Rakesh Ayer Hamid Badali Maciej Banach Amrit Banstola Aleksandra Barać Abate Bekele Belachew Charles Birungi Nicola Luigi Bragazzi Nicholas J K Breitborde Lucero Cahuana-Hurtado Josip Car Ferrán Catalá-López Abigail Chapin Catherine S Chen Lalit Dandona Rakhi Dandona Ahmad Daryani Samath D Dharmaratne Manisha Dubey Dumessa Edessa Erika Eldrenkamp Babak Eshrati André Faro Andrea B Feigl Ama Pokuaa Fenny Florian Fischer Nataliya A Foigt Kyle J Foreman Mamata Ghimire Srinivas Goli Alemayehu Hailu Samer Hamidi Hilda L Harb Simon I Hay Delia Hendrie Gloria Ikilezi Mehdi Javanbakht Denny John Jost B Jonas Alexander Kaldjian Amir Kasaeian Yawukal Chane Kasahun Fakher Rahim Young‐Ho Khang Jagdish Khubchandani Young‐Eun Kim Jonas M Kinge Soewarta Kosen Kristopher J Krohn G Anil Kumar Alessandra Lafranconi Hilton Y. Lam Stefan Listl Hassan Magdy Abd El Razek Mohammed Magdy Abd El Razek Azeem Majeed Reza Malekzadeh Déborah Carvalho Malta Gabriel Martínez George A. Mensah Atte Meretoja Angela E Micah Ted R. Miller Erkin М Мirrakhimov Fitsum Weldegebreal Mlashu Ebrahim Mohammed Shafiu Mohammed Mark Moses Seyyed Meysam Mousavi Mohsen Naghavi Vinay Nangia Frida Ngalesoni Cuong Tat Nguyen Trang Huyen Nguyen Yirga Legesse Niriayo Mehdi Noroozi Mayowa Owolabi Tejas Patel David M. Pereira Suzanne Polinder Mostafa Qorbani Anwar Rafay Alireza Rafiei

Achieving universal health coverage (UHC) requires financing systems that provide prepaid pooled resources for key services without placing undue financial stress on households. Understanding current and future trajectories of is vital progress towards UHC. We used historical data 188 countries from 1995 to 2015 estimate scenarios spending through 2040.We extracted gross domestic product (GDP) 2015, projected annual GDP, development assistance health, government, out-of-pocket, private 2040...

10.1016/s0140-6736(18)30697-4 article EN cc-by The Lancet 2018-04-17
Joseph L. Dieleman Madeline Campbell Abigail Chapin Erika Eldrenkamp Victoria Y. Fan and 95 more Annie Haakenstad Jennifer Kates Zhiyin Li Taylor Matyasz Angela E Micah Alex Reynolds Nafis Sadat Matthew Schneider Reed J D Sorensen Kaja Abbas Semaw Ferede Abera Ali Kiadaliri Muktar Beshir Ahmed Khurshid Alam Reza Alizadeh‐Navaei Ala’a Alkerwi Erfan Amini Walid Ammar Carl Abelardo T. Antonio Tesfay Mehari Atey Leticia Ávila‐Burgos Ashish Awasthi Aleksandra Barać Tezera Moshago Berheto Addisu Shunu Beyene Tariku J. Beyene Charles Birungi Habtamu Mellie Bizuayehu Nicholas J K Breitborde Lucero Cahuana-Hurtado Rubén Castro Ferrán Catalá-López Koustuv Dalal Lalit Dandona Rakhi Dandona Samath D Dharmaratne Manisha Dubey André Faro Andrea B Feigl Florian Fischer Joseph R A Fitchett Nataliya A Foigt Ababi Zergaw Giref Rahul Gupta Samer Hamidi Hilda L Harb Simon I Hay Delia Hendrie Masako Horino Mikk Jürisson Mihajlo Jakovljević Mehdi Javanbakht Denny John Jost B. Jonas Saeed Karimi Young‐Ho Khang Jagdish Khubchandani Young‐Eun Kim Jonas M Kinge Kristopher J Krohn G Anil Kumar Ricky Leung Hassan Magdy Abd El Razek Mohammed Magdy Abd El Razek Azeem Majeed Reza Malekzadeh Déborah Carvalho Malta Atte Meretoja Ted R. Miller Erkin М Мirrakhimov Shafiu Mohammed Molla Gedefaw Vinay Nangia Stefano Olgiati Mayowa Owolabi Tejas Patel Ángel Paternina‐Caicedo David M. Pereira Julian Perelman Suzanne Polinder Anwar Rafay Vafa Rahimi‐Movaghar Rajesh Kumar Usha Ram Chhabi Lal Ranabhat Hirbo Shore Roba Miloje Savic Sadaf G Sepanlou Braden Te Ao Azeb Gebresilassie Tesema A. J. Thomson Ruoyan Tobe-Gai Roman Topór-Mądry Eduardo A. Undurraga Verónica Vargas

The amount of resources, particularly prepaid available for health can affect access to care and outcomes. Although spending tends increase with economic development, tremendous variation exists among financing systems. Estimates future be beneficial policy makers planners, identify gaps. In this study, we estimate gross domestic product (GDP), all-sector government spending, disaggregated by source, compare expected potential spending.We extracted GDP, in 184 countries from 1980-2015, spend...

10.1016/s0140-6736(17)30873-5 article EN cc-by The Lancet 2017-04-19

Curcumin, an active ingredient of Curcuma longa Linn (Zingiberaceae), has shown potential antidepressant‐like activity in animal studies. The objectives this trial were to compare the efficacy and safety curcumin with fluoxetine patients major depressive disorder (MDD). Herein, 60 diagnosed MDD randomized a 1:1:1 ratio for six weeks observer‐masked treatment (20 mg) (1000 individually or their combination. primary variable was response rates according Hamilton Depression Rating Scale,...

10.1002/ptr.5025 article EN Phytotherapy Research 2013-07-06

<b>Background</b> : Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare immune-mediated severe cutaneous adverse reactions with incidence rate of 0.05 to 2 persons per million populations year. Drugs the most commonly implicated in 95% cases. <b>Aims</b> To audit causative drugs, clinical outcome, cost management SJS, TEN, SJS-TEN overlap. Setting Design: Tertiary care hospitals-based multicentric retrospective study (case series). <b>Materials Methods</b> Indoor...

10.4103/0022-3859.81865 article EN Journal of Postgraduate Medicine 2011-01-01

To find out the most common bacterial pathogens responsible for post-operative wound infection and their antibiotic sensitivity profile.This prospective, observational study was carried in patients of postoperative infection. Samples from discharge were collected using a sterile swab studied identification isolates by Gram stains culture growth followed vitro susceptibility testing performed disc diffusion method on Mueller Hinton agar.Out 183 organisms, 126 (68.85%) isolated organisms gram...

10.4103/0976-500x.83279 article EN Journal of Pharmacology and Pharmacotherapeutics 2011-07-29

Objective:To analyze the effects on pain, function, and safety of aceclofenac compared with other nonsteroidal anti-inflammatory drugs (NSAIDs) or pain relief medications in patients osteoarthritis.Material Methods: Two investigators independently searched database.We included randomized controlled trials evaluating efficacy and/or control interventions (NSAIDs acetaminophen) osteoarthritis.We did not include placebo, opioid analgesics, NSAID combinations, topical analgesics for groups.We...

10.5152/eurjrheum.2017.160080 article EN cc-by-nc European Journal of Rheumatology 2017-03-01

10.24251/hicss.2025.129 article EN Proceedings of the ... Annual Hawaii International Conference on System Sciences/Proceedings of the Annual Hawaii International Conference on System Sciences 2025-01-01

Antimicrobial resistance (AMR) poses a global health threat, emphasizing the need for Point Prevalence Surveys (PPS) to understand antibiotic use and resistance. This study assesses patterns in tertiary care hospitals across India inform AMR interventions. cross-sectional survey was conducted over two weeks between May August 2023 eight Indian hospitals. The comprised parts: ward form, which captured details (name, specialty, bed count, use), patient documented demographics, antimicrobial...

10.1016/j.eclinm.2025.103175 article EN cc-by-nc-nd EClinicalMedicine 2025-04-01

Background: Bacopa monnieri, a medicinal herb, is widely used for its cognitive-enhancing properties. The stability of active component, Bacoside-A, in commercially available formulations, influenced by packaging materials. High-Performance Thin-Layer Chromatography (HPTLC) reliable technique the quantification Bacoside-A. Aim: This study aims to validate HPTLC method Bacoside-A formulations and evaluate impact materials on these formulations. Methods: was validated following ICH Q2 (R1)...

10.18311/jnr/2025/36077 article EN Journal of Natural Remedies 2025-04-04

Purpose: To undertake an audit of the antimicrobial (AM) sensitivity pattern bacterial isolates in intensive care units (ICU) a tertiary hospital Bhavnagar, India.Methods: Retrospective analysis indoor case papers ICUs from January 2010 to 31st March 2011 was carried out at Department Pharmacology, Govt. Medical College and Sir Takhtsinhji General Hospital, India. Information collected include demographic data patient, admission unit, duration stay, diagnosis, type infection, empirical...

10.4314/tjpr.v11i6.17 article EN cc-by Tropical Journal of Pharmaceutical Research 2013-02-25

Aims: The aim of this study is to evaluate the drug utilization pattern and pharmacoeconomic analysis in critical care unit (CCU). Materials Methods: Indoor case papers patients admitted CCU between January 2008 December 2010 were analyzed for demographic variables; indications; duration stay; proportion common drugs used. Use antimicrobials was evaluated based on culture report empirical regimen Defined daily dose (DDD)/100 bed-days calculated. Various World Health Organization prescribing...

10.4103/2229-5151.124128 article EN International Journal of Critical Illness and Injury Science 2013-01-01

To evaluate the use of potentially inappropriate medicines in elderly inpatients a tertiary care teaching hospital.Retrospective analysis was performed for cases patients admitted between January 2010 and December 2010. Data on age, gender, diagnosis, duration hospital stay, treatment, outcome were collected. Prescriptions assessed medications geriatric by using American Geriatric Society Beer's criteria (2012) PRISCUS list (2010).A total 676 (52.12% females) medicine ward. The average age...

10.4103/2229-3485.140562 article EN cc-by-nc-sa Perspectives in Clinical Research 2014-01-01

To evaluate drug utilization pattern in terms of defined daily dose along with pharmacoeconomic analysis geriatric patients admitted medical ward a tertiary care hospital.Retrospective record was performed for indoor cases the (age ≥65 years) medicine from January 2010 to December were analyzed demographics, indications admission, various systems involved, duration hospital stay, drugs prescribed, and adverse reaction. The categorized by anatomical therapeutic classification calculated....

10.4103/0976-500x.124411 article EN Journal of Pharmacology and Pharmacotherapeutics 2014-01-04

The epidemiological data based on intensive monitoring studies are limited for the cutaneous adverse drug reactions (CADRs) in terms of incidence. Most earlier Indian focused only types and causative drugs CADRs.The aim this study is to analyze CADRs with reference incidence, its subgroup analysis, drugs, other clinical characteristics population.Intensive was carried out over a period 3 years dermatology outpatient inpatient department. due systematically administered were considered. WHO...

10.4103/ijd.ijd_703_16 article EN cc-by-nc-sa Indian Journal of Dermatology 2017-01-01
Coming Soon ...